Amezinium metilsulfate
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
6-Methoxy-1-phenylpyridazin-1-ium-4-amine; methyl sulfate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number |
30578-37-1 |
| ATC code | C01CA25 (WHO) |
| PubChem | CID 71926 |
| ChemSpider |
64937 |
| UNII |
03NR868ICX |
| KEGG |
D01304 |
| ChEMBL |
CHEMBL2106667 |
| Chemical data | |
| Formula | C12H15N3O5S |
| Molar mass | 313.32 g/mol |
| |
| |
| | |
Amezinium metilsulfate (INN, trade name Regulton) is a sympathomimetic drug used for the treatment of low blood pressure. It has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake.[1][2]
References
- ↑ Araújo, D; Caramona, MM; Osswald, W (1983). "On the mechanism of action of amezinium methylsulphate on the dog saphenous vein". European Journal of Pharmacology 90 (2–3): 203–14. doi:10.1016/0014-2999(83)90238-8. PMID 6873182.
- ↑ Lenke, D.; Gries, J.; Kretzschmar, R. (1981). "Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action". Arzneimittel-Forschung 31 (9a): 1558–1565. PMID 7197970.
| ||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
